Welcome to our succinct summaries of the most recent healthcare news and research. Keep yourself informed with our easily digestible updates sourced from medical media and news outlets. Estimated Exposure to 6 Potentially Hepatotoxic Botanicals in US Adults Study Details | Source Suicide Rates Among Physicians Compared With the General Population in Studies From 20 […]
The American Urological Association (AUA) stands as the leading urologic association, offering invaluable support to the global urologic community and its 23,000 members. Their mission is to advance the highest standards of urological clinical care through education, research, and the development of healthcare policies. AUA’s Clinical Practice Guidelines provide evidence-based guidance with a clear scope […]
Hemophilia A and B, the most common severe hereditary bleeding disorders, arise from deficiencies in factor VIII and factor IX, respectively. These conditions result in prolonged bleeding episodes, which can occur spontaneously or with minimal trauma, depending on the level of factor activity. Apart from treating acute bleeding, prophylaxis is a key strategy in hemophilia […]
This Ovarian Cancer Awareness Month 2024, we will be looking into the latest research and clinical trials focused on ovarian cancer in adults. The following list has been carefully curated by evaluating the ongoing Phase 3 trials for ovarian cancer, specifically targeting adults in the United States. Please note that the dates provided are approximate […]
A list of clinical practice guidelines and guideline summaries that were updated or published in August 2024.
A list of all the FDA approved medications in August 2024.
The Food and Drug Administration (FDA) protects public health by guaranteeing the safety, effectiveness, and security of pharmaceuticals and medical devices. The Prescription Drug User Fee Act (PDUFA) date marks the deadline by which the FDA must complete its review of drug applications. Occasionally, an advisory committee (AdCom) meeting is convened to assess the drug […]
In this post, we will be taking a closer look at some of the most popular oncology / hematology-related articles recently published across medical journals. Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR–Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer First-Line Nivolumab Plus Relatlimab Versus Nivolumab Plus […]
Gout is a common medical condition characterized by the accumulation of monosodium urate (MSU) monohydrate crystals in the tissues, often resulting in painful flares that can last for one to two weeks. According to the National Institutes of Health (NIH), gout is more prevalent in men than in women and typically presents in middle age. […]
The American Academy of Ophthalmology (AAO) is the largest association of eye physicians and surgeons globally. Their mission is to protect vision and enhance quality of life by establishing the benchmarks for ophthalmic education and championing the interests of patients and the general public. AAO regularly releases Preferred Practice Pattern® guidelines (PPP) aimed at defining […]
Affecting more than one-third of adults in the US, obesity remains a pressing health challenge for both providers and patients, conferring significant risk for comorbidities such as type 2 diabetes, obstructive sleep apnea, and cardiovascular disease. While lifestyle modifications and medical therapies, including anti-obesity medications (AOM), can be effective for some, they often fall short […]
On July 2, 2024, the US Food and Drug Administration (FDA) granted approval for Eli Lilly’s Kisunla (donanemab-azbt) injection for the treatment of Alzheimer’s disease. This treatment is recommended for patients in the early stages of the disease, specifically those with mild cognitive impairment or mild dementia, as demonstrated in the clinical trials. Kisunla marks […]
High cholesterol, also known as hyperlipidemia, affects millions of individuals in the United States (US). This condition can lead to serious health issues, such as an increased risk of heart disease and stroke. Globally, approximately one-third of cases of ischaemic heart disease are linked to high cholesterol levels. Elevated total cholesterol is a significant contributor […]
In this post, we will be taking a closer look at some of the most popular sleep medicine-related articles recently published across medical journals. Longer-term effect of physical activity intervention on sleep quality: a secondary analysis of cluster randomized controlled trial Delayed school start time is associated with better sleep, mental health, and life satisfaction […]
Welcome to our succinct summaries of the most recent healthcare news and research. Keep yourself informed with our easily digestible updates sourced from medical media and news outlets. Aspirin Use and Incidence of Colorectal Cancer According to Lifestyle Risk Study Details | Source Impact of Inflammation on Cognitive Function in Patients With Highly Inflammatory Rheumatoid Arthritis […]
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by systemic inflammation primarily affecting the synovial joints. This condition arises from an aberrant immune response targeting the synovium, leading to persistent inflammation, joint damage, and potential systemic manifestations. If left untreated, RA can cause significant damage to the joints and surrounding tissues, potentially leading to […]
The American Geriatrics Society (AGS) Beers Criteria® for Potentially Inappropriate Medication (PIM) Use in Older Adults is a widely recognized and utilized tool in the healthcare community. The AGS Beers Criteria is regularly updated every 3-4 years to ensure its relevance and accuracy in guiding healthcare professionals in prescribing medications for individuals aged 65 and […]
Duchenne Muscular Dystrophy (DMD) is a severe inherited neuromuscular disorder caused by mutations in the dystrophin gene. It leads to progressive muscle wasting and irreversible functional decline. Primarily affecting males due to X-linked recessive inheritance, DMD can also rarely affect females. Symptoms include gradual muscle atrophy and fibrous tissue replacement in skeletal and cardiac muscles. […]
Today, we will be looking into the latest research and clinical trials focused on respiratory syncytial virus (RSV) immunization in adults. The following list has been carefully curated by evaluating the ongoing Phase 3 trials for RSV vaccinations, specifically targeting adults in the United States. Please note that the dates provided are approximate and subject […]
In the latest edition of our Guidelines+ Trials Rundown Series, we delve into the most recent research and clinical trials focusing on multiple myeloma (MM) in adults. The following list has been carefully curated by evaluating the ongoing Phase 3 trials for MM, specifically targeting adults in the United States. Please note that the dates […]
Thyroid eye disease (TED), also known as Graves’ orbitopathy, is a complex immune-mediated disorder characterized by the aberrant proliferation of orbital fibroblasts, adipogenesis, glycosaminoglycan and mucin deposition. This connective tissue remodeling results in edematous, fibrotic adipose tissue and inflammation within the orbit and underlies the consequential classic presentation of proptosis, where the eyes appear pushed […]
A list of all the FDA approved medications in July 2024.
A list of clinical practice guidelines and guideline summaries that were updated or published in July 2024.
Obesity remains a pervasive health challenge affecting a significant portion of the population worldwide, with implications extending beyond physical appearance to encompass profound metabolic and cardiovascular risks. As medical understanding evolves, the focus on effective weight management strategies has intensified, supported by advancements in pharmacotherapy. As recommendations and anti-obesity medications (AOM) pharmacotherapies evolve, understanding the […]
The Food and Drug Administration (FDA) protects public health by guaranteeing the safety, effectiveness, and security of pharmaceuticals and medical devices. The Prescription Drug User Fee Act (PDUFA) date marks the deadline by which the FDA must complete its review of drug applications. Occasionally, an advisory committee (AdCom) meeting is convened to assess the drug […]